SWAPNA GODAVARTHI: Open Payments
NPI 1538696497 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$259 in 7 payments from 5 companies in 2025. Trend: 2023 $444 · 2024 $484 · 2025 $259
Food & beverage: $259
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 1 | $133 |
| Amgen Inc. | 3 | $67 |
| Actelion Pharmaceuticals US, Inc. | 1 | $25 |
| Boston Scientific Corporation | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: SAPIEN 3 Ultra RESILIA, REPATHA, OPSUMIT, General - Brady, FARXIGA.
Industry payments across TX — which companies pay providers there.
